TB chemoprophylaxis - PowerPoint PPT Presentation

1 / 19
About This Presentation
Title:

TB chemoprophylaxis

Description:

TB chemoprophylaxis Graham Bothamley Clinical Director, NE London TB Network Questions Do we know who will develop TB? Who should take treatment? – PowerPoint PPT presentation

Number of Views:256
Avg rating:3.0/5.0
Slides: 20
Provided by: ersnetOrg
Category:

less

Transcript and Presenter's Notes

Title: TB chemoprophylaxis


1
(No Transcript)
2
TB chemoprophylaxis
  • Graham Bothamley
  • Clinical Director, NE London TB Network

3
Questions
  • Do we know who will develop TB?
  • Who should take treatment?
  • How many will receive unnecessary treatment?
  • How many actually take treatment?
  • Is it cost-effective?
  • Is isoniazid the right treatment?

4
Latent TB infection or long-lasting TB immunity?
  • Cochrane review 1.68 over 5 years
  • HIV PPD cohort 4 over 22 months (7.9 cases
    per 100 person years)
  • Human macrophages cannot kill Mtb
  • 1-3 tubercle bacilli required for disease
  • Selwyn et al. 1989. NEJM 320 545

5
Children tuberculin responses, risk of TB over
first 9 years and timing of exposure
Horsburgh. NEJM 2004 3502060 US data 1962-1974
6
Adults tuberculin responses, risk of TB over
first 9 years and timing of exposure
Horsburgh. NEJM 2004 3502060 US data 1962-1974
7
Progression to TBImmigrant contacts of Sve
cases gt16 yrs in Holland
All IGRA patients had PPDgt10 mm 1/8 patients
missed if 15 mm Kaplan Meier for progression, pos
vs. neg even PPD gt15 mm P0.081 812 contacts
from 380 index cases Kik et al. Eur Respir J
2010 (in press)
8
Predictive values of IGRA
TBNET review Diel et al (ECDC)
9
PPD NNT to prevent 1 case TB
Rose. Arch Intern Med 2000 1601513
10
Treatment and harm
  • Treat 72 to prevent one case of TB
  • Treat 333 to cause isoniazid induced hepatitis
    (varies with age)

11
Hepatotoxicity of isoniazid
Comstock Edwards. Am Rev Respir Dis 1795 111
573
12
Adherence
  • Horsburgh et al. Chest 2010 137 401-9
  • 32 clinics
  • 123/720 declined (17.1 14.5 - 20)
  • 1045/1994 (52.4) failed to complete
  • IJTLD 2008 12 1235 1352
  • 3582 seen
  • 8 had TB (0.2)
  • PPD 996
  • 227 refused and only 40 eligible (gt35 yrs)
  • 320 (8.9 total 67 who started) completed

13
Isoniazid
  • Active against rapidly dividing population
  • Course longer than TB treatment
  • Most hepatotoxic of TB drugs
  • Cheap

14
Chemoprophylaxis?
  • 3 year old
  • Mother has smear-positive pulmonary tuberculosis
  • BCG vaccinated
  • PPD 5 mm response

15
Chemoprophylaxis?
  • 16 year old
  • Somali
  • Mother had LN TB
  • BCG vaccinated
  • PPD 12 mm response

16
Chemoprophylaxis?
  • 34 year old Russian
  • Screened as a new entrant to EU
  • Chest x-ray normal
  • PPD 35 mm response

17
Chemoprophylaxis?
  • 45 year old health care worker
  • Occupational health screening
  • To work with HIV
  • Born in UK
  • Visited relatives in India for 3m last year
  • Chest x-ray normal
  • PPD 16 mm response

18
Chemoprophylaxis?
  • 37 year old from Guinea-Bissau
  • HIV
  • BCG vaccinated
  • PPD 15 mm response

19
Chemoprophylaxis?
  • 45 year old from Turkey
  • Screened as new entrant
  • BCG vaccinated
  • Chest x-ray one calcified granuloma
  • PPD 12 mm response
  • Quantiferon 0.52 IU/ml (gt0.35 IU/ml)
Write a Comment
User Comments (0)
About PowerShow.com